Discover results from a pilot study of NBMI (Emeramide) in mercury-exposed gold miners in Zaruma, Ecuador. The 300 mg/day group showed significant reduction in physical fatigue and promising improvements in symptoms and urinary mercury levels despite ongoing exposure.